Our VisionXTransplant will abolish the organ donor shortage crisis by providing immediate access to transplantable hearts for patients with heart failure.
LEARN MORE
Our Science and BusinessmodelXTransplant is world leading in preclinical cardiac xenotransplantation and has exclusive access to unique strains of donor pigs.
LEARN MORE
About Us - Meet the TeamXTransplant will improve the quality of life and prolong the life of patients with terminal heart failure.
LEARN MOREOur Vision
Intellectual properties and therefore freedom to operate combined with a strong international network of partners will facilitate the clinical translation of cardiac xenotransplantation.
For the first time, the current and previous results of XTransplant’s cardiac xenotransplantations fulfill the pre-clinical efficacy suggestions.
Our Science and Businessmodel
XTransplant's breakthrough in xenogeneic heart transplantation:
XTransplant achieves worldwide best results after life-supporting xenogeneic heart transplantation in pre-clinical studies.
Efficacy recommendations of the International Society for Heart and Lung Transplantation (ISHLT) are achieved by XTransplant in order to start clinical trials.
Winner of Medical Valley Start-Up-Award 2019 (EUR 250K):
XTransplant represents a spin-off of the University of Munich (Ludwig-Maximilians Universität) and German Research Foundation (DFG).About Us - Meet the Team
XTransplant's intellectual properties combined with strong international partners propels the clinical translation of cardiac xenotransplantation.
Newsroom
